eXIthera Pharmaceuticals
Westborough, US · Founded 2012 · Delaware corporation
Founders & leadership
NJ
Neil J. HaywardChief Executive Officer of the Issuer.
Board
FS
Frans StassenBoard director
WK
William KosterBoard director
SY
Scott YapheBoard director
FM
Fred MeyerBoard director
IK
Isaac KohlbergBoard director
Reported raises · per SEC filings
Form D private placements$13M disclosed across 2 rounds · 2014–2017
▶$3MraisedAug 2017 · 2 investors · BiotechnologyRule 506(b)
▶$3MraisedAug 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frans StassenDirector
- Fred MeyerDirector
- Scott YapheDirector
- Neil J. HaywardExecutive Officer, Director
- William KosterDirector
- Offering amount
- $5.4M
- Amount sold
- $3M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedMay 2016 · 2 investors · BiotechnologyRule 506(b)
▶$10MraisedMay 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frans StassenDirector
- William KosterDirector
- Neil J. HaywardExecutive Officer, Director
- Scott YapheDirector
- Fred MeyerDirector
- Isaac KohlbergDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has eXIthera Pharmaceuticals raised?
- eXIthera Pharmaceuticals has disclosed $13M raised across 2 rounds.
- Where is eXIthera Pharmaceuticals headquartered?
- eXIthera Pharmaceuticals is headquartered in Westborough, US.